PT Siloam International Hospitals Tbk. Indonesia s Largest, Fastest Growing, World Class Hospital Group Q2 2014

Transcription

1 PT Siloam International Hospitals Tbk Indonesia s Largest, Fastest Growing, World Class Hospital Group Q2 2014

2 Disclaimer This presentation has been prepared by PT Siloam International Hospitals, Tbk (SILO ) and is circulated for the purpose of general information only. It is not intended for any specific person or purpose and does not constitute a recommendation regarding the securities of SILO. No warranty ( expressed or implied ) is made to the accuracy or completeness of the information. All opinions and estimations included in this report constitute our judgment as of this date and are subject to change without prior notice. SILO disclaims any responsibility or liability whatsoever arising which may be brought against or suffered by any person as a result of reliance upon the whole or any part of the contents of this presentation and neither SILO nor any of its affiliated companies and their respective employees and agents accept liability for any errors, omission, negligent or otherwise, in this presentation and any inaccuracy herein or omission here from which might otherwise arise. Forward Looking Statements The information communicated in this presentation contains certain statements that are or may be forward looking. These statements typically contain words such as will, expects and anticipates and words of similar import. By their nature, forward looking statements involve a number of risks and uncertainties that could cause actual events or results to differ materially from those described in this presentation. Factors that could cause actual results to differ include, but are not limited to, economic, social, and political conditions in Indonesia ; the state of the property industry in Indonesia; prevailing market conditions; increases in regulatory burdens in Indonesia, including environmental regulation and compliance cost; fluctuations in foreign currency exchange rates; interest rate trends, cost of capital and capital availability; the anticipated demand and selling prices for SILO developments and related capital expenditures and investments; the cost of construction; availability of real estate property; competition from other companies and venues; shifts in customer demands; changes in operation expenses, including employee wages, benefits, and training, governmental and public policy changes; SILO s ability to be and remain competitive; SILO s financial condition, business strategy as well as the plans and objectives of SILO s management for future operations; generation of future receivables; and environmental compliance and remediation. Should one or more of these uncertainties or risks, among others, materialize, actual results may vary materially from those estimated, anticipated or projected. Specifically, but without limitation, capital costs could increase, projects could be delayed and anticipated improvements in production, capacity or performance might not be fully realized. Although SILO believes that the expectations of its management as reflected by such forward looking statements are reasonable based on information currently available to us, no assurances can be given that such expectations will prove to have been correct. You should not unduly rely on such statements. In any event, these statements speak only as of the date hereof, and SILO undertakes no obligation to update or revise any of them, whether as a result of new information, future events or otherwise.

3 Contents Where We Are In Lippo Karawaci 01 Highly Experienced & Professional Management 02 The Vision 03 The Operations 04 The Strategy & Business Model Premier Private Hospital Group Financial & Operational Performance 13 21

4 Highlights Successfully completed IPO on September 12, Share Price Performance Closing Price (Rp) 15,000 14,000 13,000 12,000 11,000 10,000 9,000 10,400 10,150 SILO IJ ,600 Sept Oct Nov Dec Jan Feb Mar Apr May June Hospitals in operation as of June 30, Hospitals 10,500 10,300 Q2 results on track to achieve 40% growth in GOR and 14.5% EBITDA to GOR in ,500 Expansion plan to 40 hospitals by end of 2017 is on track. 29 projects in the pipeline in different stages of completion. Medical tourism project in Bali on track, Australia as the main target. Application for Accreditation with the Australian Council on Healthcare Standards (ACHS) was approved on July 17, , ,000 15,000 14,450

5 Where We Are In Lippo Karawaci 01 LIPPO RELATED COMPANIES 25.66% PUBLIC % As of 30 June 2014 No. of Outstanding Shares : 23,077,689,619 Code : LPKR.JK ; LPKR IJ DEVELOPMENT REVENUE RECURRING REVENUE RESIDENTIAL & URBAN DEVELOPMENT HOSPITALS COMMERCIAL ASSET MANAGEMENT Lippo Village Lippo Cikarang Tanjung Bunga San Diego Hills Memorial Park Kemang Village The St. Moritz City of Tomorrow Park View Apartments The Nine Residence Holland Village St Moritz Panakukang Embarcadero Siloam Hospitals Retail Malls Aryaduta Hotels Town Management Services, Leisure and Restaurants REIT, Mall & Hotel Management

6 Highly Experienced & Professional Management 02 Board of Commissioners Ketut Budi Wijaya President Commissioner dr. Gershu Paul Group Executive Chairman Theo L. Sambuaga Commissioner Lambock V. Nahattands Commissioner Rahmawaty Commissioner Farid Harianto Independent Commissioner Prof. Dr. H. Muladi, S.H Independent Commissioner Ir. Jonathan L. Parapak Independent Commissioner Board of Directors Romeo Lledo President Director dr. Andry Director, Chief Enterprise & Operational Officer dr. Anang Prayudi Director, Network and Development dr. Grace Frelita Director, Quality Kailas N. Raina Director, Chief Financial Officer Prof. George Mathew Director, Talent and Development

7 The Vision 03 International Quality Godly Compassion Reach By Beds 3,900 to 10,000 Patients per annum 2 million to 15 million Hospitals 17 to 40 hospitals 13 to over 25 cities Scale Affordable and Accessible Healthcare to all socio economic segments

8 The Operations 04 Unrivalled scale across Indonesia Sumatra Population : 50.6 mio Sulawesi Population : 17.4 mio Maluku Population : 2.6 mio JCI Standard Kalimantan Population : 13.8 mio Papua Population : 3.6 mio Java Population : mio Nusa Tenggara Population : 9.2 mio Bali Population : 3.9 mio Operational Hospitals (17) Future Developments (29) Greater Jakarta Population : 28 mio Jakarta Population : 10 mio

9 The Strategy & Business Model 05 4 Pillar Foundation 1 Emergency 2 Technology 3 Telemedicine 4 Doctors Excellence in Emergency Services State-of-the-Art Medical Equipment and Systems Digital Telemedicine Hub and Spoke Siloam Doctor Partnership and Development Program 4 Pillar Foundation Siloam Hospitals four pillar foundation has been key to the success of our existing hospitals and will serve as the basis for replicating this success at our expansion hospitals

10 The Strategy & Business Model 06 Clinical Service Delivery Siloam s Integrated Healthcare Delivery Model Access to Centres of Excellence through hub and spoke system and Telemedicine 3 Quaternary Integrated Centres of Excellence: Neuroscience, Cardiology, Cancer, Orthopedic, Urology, Fertility Hub and Spoke strategy and extensive coverage of specialised services via Digital Tele-Medicine Pioneering investments in Indonesia s healthcare sector Comprehensive Cancer Centre opened in 2011 Indonesia s first Gamma Knife installed in 2012 High standard and accessible medical care through focus on clinical governance and affordable price points 2 Tertiary Secondary Best in class and highly accessible healthcare services platform through: Rapid expansion of hospital network across Indonesia Attracting and retaining the best doctors with strong focus on doctors welfare (SDPDP) Equip hospitals with State-of-the-Art facilities such as 128 slice CT Scan and 1.5T MRI Specialist access for primary healthcare demand Public-Private- Partnership 1 Primary Primary clinics for corporate clients Public-Private-Partnership (PPP) model - Siloam Puskesmas (Public Health Clinic) RSUS First general hospital using public sector model Additional demand from patients under governmental insurance and social schemes Gateway to Indonesia s Universal Healthcare Coverage and Government Health Insurance Programs Research and Education Integrated platform with UPHMS and other partnerships Medical students training at RSUS, SHLV, and SHKJ One-stop continuum of care at primary, secondary, tertiary and quaternary levels

11 The Strategy & Business Model 07 UPHMS (UPH Medical Sciences) Bringing Together Clinical, Research & Education Alignment across teaching and service delivery Affiliate with agencies such as ACORN/NUS/SGH/UOM Leading edge research Centre of Excellence and Global Reputation Clinical Best practice Models Remote Access Diagnosis (RAD) and Remote Access Clinical Management (RACM) Telemedicine Centres of Clinical Excellence/ Accreditation Teaching Hospital paradigm Research Education Future workforce Systems based curriculum converged with PBL Best practice replication Clinical placement Foundation for Innovation Overseas training Singapore/Australia/USA/China

12 Premier Private Hospital Group 08 Mature and Developing Hospitals SILOAM HOSPITALS LIPPO VILLAGE TANGERANG (West of Jakarta) 308 Bed Capacity JCIA 234 GP and Specialists 455 Nurses Centre of Excellence : Neurosience & Heart Centre SILOAM HOSPITALS KEBON JERUK WEST JAKARTA 279 Bed Capacity 198 GP and Specialists 342 Nurses Centre of Excellence : Urology & Orthopaedic SILOAM HOSPITALS SURABAYA EAST JAVA 162 Bed Capacity 144 GP and Specialists 265 Nurses Centre of Excellence : Fertility Centre MRCCC SILOAM SEMANGGI SOUTH JAKARTA 331 Bed Capacity 172 GP and Specialists 220 Nurses Centre of Excellence : Cancer Centre SILOAM HOSPITALS JAMBI EAST SUMATERA 100 Bed Capacity 65 GP and Specialists 127 Nurses Centre of Excellence : Emergency & Trauma 83.0% Ownership SILOAM HOSPITALS CIKARANG BEKASI (East of Jakarta) 118 Bed Capacity 91 GP and Specialists 161 Nurses Centre of Excellence : Occupational Health SILOAM HOSPITALS BALIKPAPAN EAST KALIMANTAN 228 Bed Capacity 92 GP and Specialists 180 Nurses Centre of Excellence : Emergency & Trauma and Orthopedics 79.45% Ownership

13 Premier Private Hospital Group 09 New Hospitals in 2012 SILOAM GENERAL HOSPITAL (RSUS) TANGERANG (West of Jakarta) 664 Bed Capacity 49 GP and Specialists 214 Nurses SILOAM HOSPITALS CINERE DEPOK (South of Jakarta) 37 Bed Capacity 19 GP and Specialists 51 Nurses Centre of Excellence: Cardiology SILOAM HOSPITALS MANADO NORTH SULAWESI 230 Bed Capacity 98 GP and Specialists 126 Nurses Centre of Excellence : Emergency & Trauma 80.0% Ownership SILOAM HOSPITALS MAKASSAR SOUTH SULAWESI 360 Bed Capacity 97 GP and Specialists 247 Nurses Centre of Excellence : Cardiology and Emergency & Trauma SILOAM HOSPITALS PALEMBANG SOUTH SUMATERA 347 Bed Capacity 119 GP and Specialists 161 Nurses Centre of Excellence : Emergency & Trauma 70.39% Ownership

14 Premier Private Hospital Group 10 New Hospitals in 2013 SILOAM HOSPITALS BALI BALI 281 Bed Capacity 97 GP and Specialists 179 Nurses Centre of Excellence : Emergency & Trauma, Medical Tourism, Orthopaedics and Cardiology BIMC KUTA BALI 19 Bed Capacity 51 GP and Specialists 65 Nurses Centre of Excellence : Emergency & Trauma 80.0% Ownership SILOAM HOSPITALS TB SIMATUPANG SOUTH JAKARTA 269 Bed Capacity 110 GP and Specialists 136 Nurses Centre of Excellence : Emergency & Trauma. Cardiology, Oncology and Neuroscience BIMC NUSA DUA BALI 31 Bed Capacity 57 GP and Specialists 74 Nurses Centre of Excellence : Emergency & Cosmetic Surgery 80.0% Ownership New Hospitals in 2014 SILOAM HOSPITALS PURWAKARTA WEST JAVA 203 Bed Capacity 34 GP and Specialists 105 Nurses Centre of Excellence : Emergency & Trauma

15 Premier Private Hospital Group 11 Hospitals under Construction SILOAM HOSPITALS MEDAN NORTH SUMATERA SILOAM HOSPITALS KUPANG EAST NUSA TENGGARA There are currently 29 sites under various stages of development

16 Premier Private Hospital Group 12 Awards Indonesia Healthcare Most Reputable Brand 2014 Based on Healthcare Survey in 7 Big Cities in Indonesia (Awarded by SWA) BIMC Hospital was awarded Indonesia Healthcare Most Reputable Brand 2014 Based on Healthcare Survey in 7 Big Cities in Indonesia (Awarded by SWA) Indonesia Healthcare Most Reputable Brand 2014 Based on Healthcare Survey in Jabodetabek City (Awarded by SWA) Indonesia Healthcare Most Reputable Brand 2014 Based on Healthcare Survey in Denpasar City (Awarded by SWA) European Award For Best Practices 2014 (from European Society for Quality Research) Indonesia Healthcare Most Reputable Brand 2014 Based on Healthcare Survey in Makassar City (Awarded by SWA) Corporate Image Award 2014 The Best in Building and Managing Corporate Image - Category Hospital (Awarded by TEMPO and Frontier) Indonesia Best New Issuer 2014 (Awarded by Warta Ekonomi)

17 Operational & Financial Performance For The 6 Months Ended June 30, 2014

18 Strong Financial Performance 14 Revenue EBITDA ( In Rp Bn ) ( In Rp Bn ) 3, % +70% % +40% 2, % +35% % % +22% 1, ,259 1, % +12% % 14% +10% % +43% % % 12% P P Siloam is the clear leader and fastest growing private hospital group in Indonesia serving all segments of the population Note: EBITDA refers to income before depreciation, provisions for post-employment benefits, allowance for impairment in value, corporate income taxes and other expense and/or income (consisting primarily of financing income and others-net).

19 2014 Revenue Ramp Up 15 ( In Rp Bn ) 3, % 3, % 2,504 2,486 71% 2,501 71% 1,522 43% 1,568 45% % % 14% 2013 Q1 2014A Q2 2014A Q3 2014P Q4 2014P Guidance Actual Projection

20 Revenue & EBITDA Growth 16 Q Results by Hospital Category Revenue Contribution and Growth by Category EBITDA Contribution and Growth by Category 13% 13% 8% 13% 13% 11% 8% + 6% + 29% + 12% 6% 6% 18% 9% 8% 8% - 10% + 67% + 73% + 93% + 33% 86% + 153% + 205% 62% 51% + 736% 55% + 1,675% Q Q Mature 2 Developing MRCCC RSUS 4 New New New 2014 Q Q Mature 2 Developing MRCCC RSUS 4 New New New 2014 Commentary The decreased EBITDA of 10% of the 4 mature hospitals was primarily due to: On May 1, 2013, SIH started to incur rental expenses on the land and building being sub leased from the parent company. The total rental in Q amounted to Rp 17 billion and Q was Rp 3 billion. SHLC rental expense for its sale and leaseback agreement amounted to Rp 16 billion in Q and Rp 12 billion in Q Note: EBITDA refers to income before depreciation, provisions for post-employment benefits, allowance for impairment in value, corporate income taxes and other expense and/or income (consisting primarily of financing income and others-net).

21 Revenue & EBITDA Analyses 17 Q Consolidated Results Particulars Q Q IDR Bn IDR Bn % (i) GOR 1,201 1,568 31% Service Cost % NOR 876 1,165 33% Material Cost % Gross Margin % Operating Expenses % EBITDAR % % to GOR 15.1% 17.3% Rental (i) % HO Expenses % EBITDA (ii) % % to GOR 11.9% 13.2% NPAT % % to GOR 1.4% 2.8% Notes: (i) Represents rental expenses for the land and buldings, Siloam is leasing from FREIT, PT Lippo Karawaci Tbk and other parties. PT Lippo Karawaci started charging rent for the land and buildings of 9 hospitals on May 1, (ii) EBITDA refers to income before depreciation, provisions for post-employment benefits, allowance for impairment in value, corporate income taxes and other expense and/or income (consisting primarily of financing income and others-net).

22 Balance Sheet 18 Q Consolidated Results (i) In Rp Bn FY 2013 Q % Assets Cash & Equivalent % Property and Equipment 1,402 1,423 1% Total Assets 2,601 2,641 2% Liabilities & Equity Liabilities % Shareholders' Equity 1,639 1,682 3% D/E Ratio

23 Average Revenue Per Patient 19 Q (Rp Mn) IPD Average Revenue Per Patient Mature 2 Developing MRCCC RSUS 4 New New New Q OPD Average Revenue Per Patient (Rp Mn) Mature 2 Developing MRCCC RSUS 4 New New New Q

24 Operational Update Patient Visits & Admissions 20 Q OPD Visits (+19%) ED Visits (+27%) 0.3% 336, ,578 39,053 6% 41,389 14% 52% 75,645 18% 149% 330% 66,325 68,338 28,024 33,036 45,058 40,938 23,776 13,242 9,518-5,595 4 Mature 2 Developing MRCCC RSUS 4 New New New 2014 Q Q IPD Admissions (+30%) 19% 40% 15, % 9,183 40% 9% 11,162 9,507 7,748 2,735 2,932 2,681 1,955 2,697 4 Mature 2 Developing - 1,320 MRCCC RSUS 4 New New New 2014 Q Q % 22,973 22,846 20% 6,212 5,163 86% 26% 5,982 2,217 2,800 3,214 7,511 34% 10, % 5, ,373 Strong throughput growth at all entry points and conversion to IPD across all hospitals 4 Mature 2 Developing MRCCC RSUS 4 New New New 2014 Q Q Note: Total of OPD visits includes One Day Care Visits

25 Number of Hospital Growth to Q / Q Hospitals 7 Hospitals 12 Hospitals 16 Hospitals Q Hospitals Note: Image courtesy of iconbug.com

26 Thank You